Latest Publications

@article{uhlik_bacterial_2014,

title = {Bacterial acquisition of hexachlorobenzene-derived carbon in contaminated soil.},

author = {Ondrej Uhlik and Michal Strejcek and Jan Vondracek and Lucie Musilova and Jakub Ridl and Petra Lovecka and Tomas Macek},

doi = {10.1016/j.chemosphere.2014.04.110},

issn = {1879-1298 0045-6535},

year  = {2014},

date = {2014-10-01},

journal = {Chemosphere},

volume = {113},

pages = {141–145},

abstract = {Pesticides are a class of xenobiotics intentionally released into the environment. Hexachlorobenzene (HCB) was used as a fungicide from 1945, leaving behind many contaminated sites. Very few studies have examined the biodegradation of HCB or the fate of HCB-derived carbon. Here we report that certain bacterial populations are capable of deriving carbon from HCB in contaminated soil under aerobic conditions. These populations are primarily Proteobacteria, including Methylobacterium and Pseudomonas, which predominated as detected by stable isotope probing (SIP) and 16S rRNA gene amplicon pyrosequencing. Due to the nature of SIP, which can be used as a functional method solely for assimilatory processes, it is not possible to elucidate whether these populations metabolized directly HCB or intermediates of its metabolism produced by different populations. The possibility exists that HCB is degraded via the formation of pentachlorophenol (PCP), which is further mineralized. With this in mind, we designed primers to amplify PCP 4-monooxygenase-coding sequences based on the available pcpB gene sequence from Methylobacterium radiotolerans JCM 2831. Based on 16S rRNA gene analysis, organisms closely related to this strain were detected in (13)C-labeled DNA. Using the designed primers, we were able to amplify pcpB genes in both total community DNA and (13)C-DNA. This indicates that HCB might be transformed into PCP before it gets assimilated. In summary, this study is the first report on which bacterial populations benefit from carbon originating in the pesticide HCB in a contaminated soil.},

note = {Place: England},

keywords = {*Soil Microbiology, 16S rRNA genes, 16S/genetics, Amplicon pyrosequencing, Biodegradation, Bioremediation, Carbon Isotopes/metabolism, Czech Republic, DNA, DNA Primers, Environmental, Hexachlorobenzene/chemistry/*metabolism, Isotope Labeling, Methylobacterium/*metabolism, Mixed Function Oxygenases/metabolism, Molecular Structure, Pentachlorophenol 4-monooxygenase, Pentachlorophenol/chemistry/metabolism, Pesticides, Pseudomonas/*metabolism, Real-Time Polymerase Chain Reaction, Ribosomal, RNA, Sequence Analysis, Soil Pollutants/*metabolism, Stable isotope probing},

pubstate = {published},

tppubtype = {article}

}

@article{horvath_platinumiv_2006,

title = {Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.},

author = {Viktor Horváth and Olga Blanárová and Lenka Svihálková-Sindlerová and Karel Soucek and Jirina Hofmanová and Petr Sova and Ales Kroutil and Peter Fedorocko and Alois Kozubík},

doi = {10.1016/j.ygyno.2005.11.016},

issn = {0090-8258},

year  = {2006},

date = {2006-07-01},

journal = {Gynecologic oncology},

volume = {102},

number = {1},

pages = {32–40},

abstract = {OBJECTIVES: The resistance of tumor cells to cisplatin remains a major cause of treatment failure in cancer patients. In this study, the ability of Pt(IV) complex with adamantylamine-LA-12 and its reduced counterpart with lower oxidation state Pt(II)-LA-9 to overcome intrinsic cisplatin resistance was investigated. METHODS: The ovarian adenocarcinoma SK-OV-3 cells were exposed to cisplatin, LA-9, or LA-12 for 72 h and the effects of drug concentrations that caused 10% or 50% inhibition of cell proliferation were determined. After 24-72 h of sustained exposure viability, apoptosis and inhibition of proliferation were analyzed. DNA synthesis and cell cycle analysis were performed simultaneously in order to determine the modulation of cell cycle after platinum complexes treatment. RESULTS: Lung Resistance-related Protein (LRP/MVP) was detected in SK-OV-3 cells but not in the other two ovarian cancer lines with different sensitivity to cisplatin. LRP/MVP overexpression may be an important factor contributing to intrinsic cisplatin resistance. Interestingly, Pt(IV) complex-LA-12 had approximately 2.7-fold lower IC(50) concentration than LA-9 or cisplatin in SK-OV-3 cells. Moreover, LA-12 caused persistent accumulation of cells in S-phase of the cell cycle while LA-9 and cisplatin treatment-induced S-phase arrest was transient and shifted to G(2)/M-phase at later intervals. Apoptosis seemed to be not the dominant type of cell death caused by such the derivatives, but it was the most intensive after LA-12 treatment. CONCLUSIONS: We found strong differences between effects of Pt(IV) complex-LA-12 and Pt(II) derivatives-LA-9 and cisplatin on cytokinetic parameters. Overall, LA-12 but not its reduced Pt(II) counterpart LA-9 is the compound effective in p53 null human ovarian cancer cells and it is able to overcome intrinsic cisplatin resistance in these cells.},

note = {Place: United States},

keywords = {Adenocarcinoma/*drug therapy/metabolism/pathology, Amantadine/administration & dosage/analogs & derivatives, Antineoplastic Combined Chemotherapy Protocols/*pharmacology, Blotting, Cell Cycle/drug effects, Cell Growth Processes/drug effects, Cell Line, Cisplatin/administration & dosage, DNA, Drug resistance, Female, Humans, Neoplasm, Neoplasm Proteins/biosynthesis, Neoplasm/biosynthesis, Organoplatinum Compounds/administration & dosage/*pharmacology, Ovarian Neoplasms/*drug therapy/metabolism/pathology, Poly(ADP-ribose) Polymerases/metabolism, Tumor, Vault Ribonucleoprotein Particles/biosynthesis, Western},

pubstate = {published},

tppubtype = {article}

}